July 15, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impair
June 28, 2022 C-Path Welcomes RWS C-Path is proud to welcome RWS as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 28, 2022 C-Path Welcomes Parexel C-Path is proud to welcome Parexel as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 24, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Progressing BYOD Adoption” has been published in Applied Clinical Tria
June 8, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
April 2, 2022 eCOA Consortium and PRO Consortium Announce Publication of Open Access Article C-Path’s eCOA Consortium and PRO Consortium are pleased to announce that “Recommendations for the Electronic Migration and
April 5, 2022 New logo! Rare Disease Cures Accelerator-Data and Analytics Platform has a new look! C-Path’s RDCA-DAP team is excited to unveil its new logo for the Rare Disease Cures Accelerator-Data and Analytics Platform
March 28, 2022 C-Path is proud to share our responses to the FDA draft guidance, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations The Clinical Outcomes Assessment (COA), Critical Path for Parkinson’s Digital Drug Development (3DT) Initiative, and Type 1 Diab